tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dogwood Therapeutics Secures Licensing Deal with Serpin Pharma
PremiumCompany AnnouncementsDogwood Therapeutics Secures Licensing Deal with Serpin Pharma
22d ago
Dogwood secures royalty free license to develop, commercialize SP16
Premium
The Fly
Dogwood secures royalty free license to develop, commercialize SP16
22d ago
Buy Rating for Dogwood Therapeutics: Promising Phase 2b Study Results and Strategic Financial Positioning
Premium
Ratings
Buy Rating for Dogwood Therapeutics: Promising Phase 2b Study Results and Strategic Financial Positioning
2M ago
Dogwood files $150M mixed securities shelf
PremiumThe FlyDogwood files $150M mixed securities shelf
5M ago
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
Premium
Ratings
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
6M ago
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
Premium
Ratings
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
6M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
Dogwood upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
Dogwood upgraded to Buy from Neutral at H.C. Wainwright
6M ago
Dogwood receives Nasdaq confirmation of compliance
Premium
The Fly
Dogwood receives Nasdaq confirmation of compliance
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100